|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/353 | (2013.01) |
| C07K 16/22 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/282 | (2006.01) | ||
| C07K 16/28 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/39558 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/507 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/22 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/282 | (2013.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61K 33/24 | (2013.01) | ||
| A61K 33/243 | (2019.01) |
| (11) | Patento numeris | 3353204 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16849686.7 |
| Europos patento paraiškos padavimo data | 2016-09-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/053316 |
| Data | 2016-09-23 |
| (87) | Numeris | WO 2017/053705 |
| Data | 2017-03-30 |
| (30) | Numeris | Data | Šalis |
| 201562222505 P | 2015-09-23 | US |
| (72) |
DUPONT, Jakob , US
PARMAR, Hema , US
STAGG, Robert Joseph , US
|
| (73) |
Mereo BioPharma 5, Inc. ,
800 W El Camino Real
Suite 180, Mountain View, CA 94040,
US
|
| (54) | BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER |
| BI-SPECIFIC ANTI-VEGF/DLL4 ANTIBODY FOR USE IN TREATING PLATINUM-RESISTANT OVARIAN CANCER |